Benitec Biopharma Inc. (BNTC)
11.75
-0.67 (-5.39%)
At close: Mar 04, 2025, 9:45 AM
Benitec Biopharma Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -5.42 | -1.15 | -2.04 | -5.3 | -3.89 | 19.27 | -13.23 | -19.28 | -2.62 | -36.44 | -38.93 | -17.67 |
| PEG Ratio | 0.09 | 0.02 | 0.07 | 0.09 | 0.01 | -0.15 | -0.21 | 0.24 | -0.04 | 1.01 | 0.67 | n/a |
| PS Ratio | 545.87 | 300.08 | 519.41 | 1.24K | 333.10 | 4.88 | 248.31 | 187.18 | 139.91 | 387.99 | 414.46 | 208.02 |
| PB Ratio | 2.50 | 111.41 | 13.16 | 3.65 | 3.16 | 3.34 | 8.21 | 5.10 | 3.45 | 17.56 | 18.76 | 3.71 |
| P/FCF Ratio | -6.02 | -1.25 | -2.38 | -5.59 | -4.23 | 12.60 | -13.13 | -9.99 | -2.37 | -31.92 | -41.49 | -12.21 |
| P/OCF Ratio | -6.08 | -1.25 | -2.38 | -5.69 | -4.29 | 11.54 | -13.23 | -10.15 | -2.4 | -33.19 | -43.52 | -12.24 |
| OCF/S Ratio | -89.83 | -240.16 | -217.79 | -217.49 | -77.68 | 0.42 | -18.77 | -18.44 | -58.32 | -11.69 | -9.52 | -16.99 |
| Debt / Equity Ratio | 0.01 | 2.77 | 0.28 | 0.01 | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 10.49 | 0.93 | 1.90 | 15.05 | 8.68 | 7.10 | 8.20 | 19.77 | 18.58 | 13.57 | 13.57 | 33.22 |
| Current Ratio | 10.49 | 0.94 | 1.90 | 15.05 | 9.51 | 7.10 | 8.20 | 19.70 | 18.73 | 15.26 | 15.26 | 36.07 |
| Asset Turnover | 0.00 | 0.02 | 0.01 | 0.00 | 0.01 | 0.59 | 0.03 | 0.03 | 0.02 | 0.04 | 0.04 | 0.02 |
| Interest Coverage | -24.88 | -578.21 | -557.94 | -2.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.46 | -96.84 | -6.44 | -0.69 | -0.81 | 0.17 | -0.62 | -0.26 | -1.32 | -0.48 | -0.48 | -0.21 |
| Return on Assets (ROA) | -0.42 | -4.38 | -3.11 | -0.64 | -0.72 | 0.15 | -0.55 | -0.25 | -1.25 | -0.45 | -0.45 | -0.2 |
| Return on Capital (ROIC) | -0.48 | -39.26 | -5.19 | -0.68 | -0.79 | 0.12 | -0.62 | -0.96 | -1.77 | -0.73 | -0.64 | -0.27 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 50.00% | -408% | 87.67% | -108.47% | -176.36% | 96.23% | 27.26% | 53.58% | 70.04% | 96.30% | 96.30% | 67.73% |
| Net Profit Margin | -10.07K% | -26.08K% | -25.43K% | -23.36K% | -8.56K% | 25.34% | -1.88K% | -970.99% | -5.34K% | -1.06K% | -1.06K% | -1.18K% |
| Pretax Profit Margin | -10.36K% | -26.08K% | -24.94K% | -23.53K% | -8.53K% | 25.34% | -1.88K% | -970.99% | -5.34K% | -1.06K% | -1.06K% | -1.25K% |
| Operating Profit Margin | -10.41K% | -25.44K% | -24.46K% | -23.04K% | -8.54K% | 17.70% | -1.88K% | -3.54K% | -7.2K% | -1.61K% | -1.41K% | -1.49K% |
| FCF Margin | -9.07K% | -24.02K% | -21.8K% | -22.12K% | -7.87K% | 38.76% | -1.89K% | -1.87K% | -5.91K% | -1.22K% | -999.01% | -1.7K% |
| EBITDA Margin | -10.41K% | -24.93K% | -24.46K% | -23.04K% | -8.15K% | 24.22% | -1.89K% | -930.55% | -3.87K% | -956.61% | -972.53% | -1.22K% |